Monoclonal antibodies provide protection against a wide range of infectious microbes, and now, in a series of elegant laboratory experiments, scientists have uncovered how a pair of these ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. GENEVA (AP) — Switzerland’s medical products ...

Malaria kills over 600,000 people a year, and as the climate warms, the potential range of the disease is growing. While some drugs can effectively prevent and treat malaria, resistance to those drugs ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The logo of Swiss drugmaker Novartis is pictured at the company's French headquarters in Rueil-Malmaison ZURICH ...

WHO has approved the first-ever paediatric primaquine tablets for malaria treatment, a breakthrough moment for malaria elimination. Developed by Medicines for Malaria Venture (MMV) and Fosun Pharma ...

This Traverse City doc’s 29 years of research in a humble African medical clinic has saved hundreds of thousands of children’s lives. Dr. Terrie Taylor isn’t done yet, though. At this particular ...

A new generation of malaria drugs failed clinical trials, in part because they were hard to swallow. UCSF chemists remodeled their structures to make them more soluble, while maintaining their ...

The International Centre for Diarrhoeal Disease Research, Bangladesh, is set to launch the first surveillance study aimed at identifying ...